Press Releases

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRMB, PRMW Leave a reply NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 and November 6, 2025 (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If you purchased Primo Brands securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Primo Brands class action, go to https://rosenlegal.com/submit-form/?case_id=47890 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB Leave a reply NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub’s September 2025 initial public offering (the “IPO”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 23, 2026. SO WHAT: If you purchased StubHub common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the StubHub class action, go to https://rosenlegal.com/submit-form/?case_id=48412 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 23, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action

ATYR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATYR Leave a reply NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased aTyr Pharma common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the aTyr Pharma class action, go to https://rosenlegal.com/submit-form/?case_id=46109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for

North Atlantic France SAS successfully completes the acquisition of a controlling stake in Esso Société Anonyme Française SA and of 100% of ExxonMobil Chemical France SAS, two independent companies of the ExxonMobil group Leave a reply   Paris, FRANCE, Nov. 28, 2025 (GLOBE NEWSWIRE) — North Atlantic France SAS successfully completes the acquisition of a controlling stake in Esso Société Anonyme Française SA and of 100% of ExxonMobil Chemical France SAS, two independent companies of the ExxonMobil group Successful completion of the acquisition by North Atlantic France SAS (“North Atlantic France”) of the 82.89% controlling interest of ExxonMobil France Holding SAS (“ExxonMobil”) in French listed company Esso Société Anonyme Française SA (“Esso S.A.F.”) at €26.19 per share and 100% of unlisted company ExxonMobil Chemical France SAS (“EMCF”) Clearance of both French Foreign Direct Investment authorization and EU Foreign Subsidies Regulation Esso S.A.F. now operating under its new name: North Atlantic Energies North Atlantic reaffirms its long-term commitment to the Gravenchon site, its employees, and France’s energy and industrial future Mandatory tender offer to be launched for the remaining Esso S.A.F. shares at €28.931 per share Paris, FRANCE – November 28, 2025 – North Atlantic France today announces the successful closing of its acquisition of an 82.89% controlling interest in Esso S.A.F. at €26.19 per share and 100% of EMCF from ExxonMobil following a competitive auction process initiated in 2024. The transaction has received all required regulatory approvals, including French foreign direct investment authorization and clearance under the EU Foreign Subsidies Regulation. As of today’s closing, Esso S.A.F. is renamed North Atlantic Energies, paving the way for the beginning of a new chapter for a key player of France’s energy and industrial landscape. Ted Lomond, President and CEO of North Atlantic Group, said: “This acquisition represents a major step forward in